ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
08 Sep 2016 10:00

Vietnam Vs. Korea (A Tale of Two Countries: 20 Investment Themes for the Next Decade) - Part I

This is a collaborative report between Dylan Waller  and Douglas Kim . This is Part I of our report: Vietnam Vs. Korea (A Tale of Two Countries: 20...

Share
bearishSamsung C&T
03 Sep 2016 10:22

Bioepis Details Don't Support the Valuation

We are following up on our previous post on the proposed listing of Samsung BioLogics US$9 Billion Valuation Is Rarefied Air  in response to...

Share
01 Sep 2016 04:37

Korea Stock Market Monthly Recap #5 - (August 2016)

Key Events in August - The launch of Galaxy S7 Note Smartphone, continued rebound of DRAM prices, the start of One-Shot Act, lingering concerns...

Logo
238 Views
Share
01 Aug 2016 15:19

Alpha Generation & Share Buybacks in Korea

Korean companies are showing increasing willingness to buyback shares. Korea Stock Exchange announced that from beginning of this year to as of 27...

Logo
640 Views
Share
bearishCelltrion Inc
28 Jul 2016 04:55

Another Payer Speaks Cautiously

Leading U.S. pharmacy benefits manager Express Scripts (ESRX US) held a conference call today to discuss its Q2: 2016 results. The company is the...

Share
x